China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64,579 | 56,263 | 51,190 | 53,844 | N/A |
| Receivables | 9,264 | 8,179 | 6,212 | 4,176 | N/A |
| Inventories | 46,584 | 41,435 | 39,175 | 35,133 | N/A |
| Other current assets | 1,286 | 1,120 | 1,335 | 1,054 | 0 |
| TOTAL | $123,392 | $108,845 | $99,585 | $95,506 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 36,992 | 35,598 | 31,868 | 28,873 | N/A |
| Investments And Advances | 7,443 | 7,002 | 6,816 | 6,627 | 0 |
| Intangibles | 31,624 | 32,414 | 32,761 | 38,381 | 0 |
| Other Non-Current Assets | 3,471 | 2,637 | 3,363 | 3,224 | 0 |
| TOTAL | $79,531 | $77,651 | $74,808 | $77,106 | $N/A |
| Total Assets | $202,923 | $186,496 | $174,393 | $172,612 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,063 | 5,966 | 11,061 | 8,054 | N/A |
| Accounts payable and accrued liabilities | 29,645 | 27,039 | 26,086 | 28,354 | 0 |
| Accrued Expenses | N/A | N/A | 1,155 | 2,069 | N/A |
| Other current liabilities | 4,121 | 4,051 | 4,554 | 36,530 | N/A |
| TOTAL | $48,104 | $44,953 | $50,375 | $83,869 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 175 | N/A | N/A |
| Other Non-Current Liabilities | 13,535 | 15,748 | 20,624 | -5,554 | -3,413 |
| TOTAL | $18,718 | $22,506 | $24,951 | $4,599 | $N/A |
| Total Liabilities | $66,822 | $67,459 | $75,325 | $88,468 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,214 | 23,514 | 23,521 | N/A | N/A |
| Common Shares | 2 | 2 | 2 | 2 | N/A |
| Retained earnings | 33,568 | 22,967 | 13,491 | 24,196 | N/A |
| Other shareholders' equity | 74,396 | 67,997 | 57,549 | 38,674 | 0 |
| TOTAL | $136,101 | $119,037 | $99,068 | $84,143 | $N/A |
| Total Liabilities And Equity | $202,923 | $186,496 | $174,393 | $172,612 | $0 |